FindTrial
Sign In

A study to assess the utility of hematological parameters (platelets, lymphocytes, neutrophils) in predicting Acute Kidney Injury

Assessing the utility of Platelet-to-Lymphocyte ratio and Neutrophil-to-Lymphocyte ratio as predictors of Acute Kidney Injury in ICU patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/068910
Enrollment
200
Registered
2024-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N179- Acute kidney failure, unspecified

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients aged 18 and above admitted to the Intensive Care Unit(ICU)

Exclusion criteria

Exclusion criteria: 1. Patients with a pre-existing diagnosis of chronic kidney disease 2. Pregnant patients 3. Patients who have had a second admission to the ICU

Design outcomes

Primary

MeasureTime frame
Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) will be used as markers to predict Acute Kidney Injury (AKI) in patients admitted to the Intensive Care Unit (ICU).Timepoint: 3 years—

Secondary

MeasureTime frame
To analyze & compare the baseline levels of Platelet-to-Lymphocyte Ratio (PLR) & Neutrophil-to-Lymphocyte Ratio (NLR) in patients with & without Acute Kidney Injury (AKI) To evaluate & determine the optimal cut-off values & Sensitivity/ Specificity of PLR & NLR for predicting the development of AKI Assess the prognostic value of PLR & NLR for in-hospital mortalityTimepoint: 2 years 6 months—

Countries

India

Contacts

Public ContactDr Chandrashekar UK

Kasturba Medical College, Manipal

shekar.uk@manipal.edu9845163448

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026